3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Multiple Myeloma
7
Recurrence
5
Neoplasms
2
Leukemia, Myeloid, Acute
2
Endometrial Neoplasms
2
Uterine Neoplasms
1
Uterine Diseases
1
Primary Myelofibrosis
1
Neoplasms by Site
1
Myeloproliferative Disorders
1
Lymphoma, Large B-Cell, Diffuse
1
Genital Diseases
1
COVID-19
1
Interventions
selinexor
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Uterine Diseases
×
selinexor
×
Clear all
NCT03555422
2026-04-13
ENGOT-EN5
Karyopharm Therapeutics Inc
Phase 3
Completed
263 enrolled